Betaloc
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
323 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 3 | 9 | 20 | 33 | 16 | 76 |
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | 5 | 7 | 13 | 12 | 37 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 2 | 2 | 5 | 10 | 12 | 30 |
| Coronary artery disease | D003324 | — | I25.1 | 1 | — | — | 6 | 12 | 19 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 2 | 2 | 8 | 1 | 13 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | 3 | 10 | 13 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | 2 | 2 | 7 | 2 | 13 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | 1 | 4 | 4 | 5 | 1 | 13 |
| Coronary disease | D003327 | — | — | — | — | 1 | 4 | 7 | 12 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 3 | 1 | 1 | 5 | 1 | 11 |
Show 84 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | 3 | — | 1 | 5 |
| Chronic renal insufficiency | D051436 | — | N18 | 1 | 2 | 1 | — | 1 | 4 |
| Burns | D002056 | — | T30.0 | — | 4 | 4 | — | — | 4 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | — | 3 | 4 |
| Ventricular tachycardia | D017180 | — | I47.2 | — | 2 | 1 | — | 2 | 4 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 1 | — | 1 | 3 |
| Renal insufficiency | D051437 | — | N19 | — | 1 | 1 | — | 1 | 3 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | 1 | — | 1 | 3 |
| Fibrosis | D005355 | — | — | — | 1 | 1 | — | 1 | 3 |
| Lung neoplasms | D008175 | — | C34.90 | — | — | 2 | — | — | 2 |
Show 29 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 20 | 1 | — | — | — | 21 |
| Tachycardia | D013610 | — | R00.0 | 1 | 2 | — | — | 4 | 7 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 4 | 1 | — | — | — | 5 |
| Dermatitis | D003872 | — | L30.9 | 4 | 1 | — | — | — | 5 |
| Eczema | D004485 | — | L30.9 | 3 | 1 | — | — | — | 4 |
| Cognitive dysfunction | D060825 | — | G31.84 | — | 2 | — | — | — | 2 |
| Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | — | 2 |
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | — | 1 | — | — | 1 | 2 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | — | — | 2 |
| Prader-willi syndrome | D011218 | Orphanet_739 | Q87.11 | — | 2 | — | — | — | 2 |
Show 19 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | 1 | 3 |
| Drug interactions | D004347 | — | — | 2 | — | — | — | 1 | 3 |
| Covid-19 | D000086382 | — | U07.1 | 1 | — | — | — | 1 | 2 |
| Pure autonomic failure | D054970 | — | — | 1 | — | — | — | 1 | 2 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
| Fasting | D005215 | EFO_0002756 | — | 2 | — | — | — | — | 2 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | — | 1 |
| Hepatitis c | D006526 | — | B19.2 | 1 | — | — | — | — | 1 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | — | 1 |
| Crohn disease | D003424 | EFO_0000384 | K50 | 1 | — | — | — | — | 1 |
Show 8 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Percutaneous coronary intervention | D062645 | — | — | — | — | — | — | 2 | 2 |
| Kidney transplantation | D016030 | — | — | — | — | — | — | 2 | 2 |
| Cerebral hemorrhage | D002543 | — | — | — | — | — | — | 2 | 2 |
| Chest pain | D002637 | — | R07.9 | — | — | — | — | 2 | 2 |
| Coronary occlusion | D054059 | — | I21 | — | — | — | — | 1 | 1 |
| Drug-eluting stents | D054855 | — | — | — | — | — | — | 1 | 1 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | — | 1 | 1 |
| Vomiting | D014839 | — | R11.1 | — | — | — | — | 1 | 1 |
| Nausea | D009325 | — | R11.0 | — | — | — | — | 1 | 1 |
| Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 1 | 1 |
Show 15 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
449 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use